Zimmer Biomet Holdings, Inc. (ZBH) Stock
Zimmer Biomet stock price chart
ZBH stock quote & key statistics
Zimmer Biomet annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $8.23B | $705.2M | $8.20 |
| FY2024 | $7.68B | $903.8M | $8.00 |
| FY2023 | $7.39B | $1.02B | $7.56 |
| FY2022 | $6.94B | $231.4M | $6.89 |
| FY2021 | $6.83B | $401.6M | $7.37 |
Fiscal year ending December 31. Source: company filings via EODHD.
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc., and its subsidiaries operate globally within the musculoskeletal healthcare sector, providing a wide range of innovative products and solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Specializing in orthopaedic reconstructive products, the company offers advanced knee and hip implants, along with a comprehensive portfolio of sports medicine, biologics, foot and ankle, extremities, and trauma care solutions. Additionally, Zimmer Biomet manufactures spine products including surgical instruments and medical devices, as well as specialized products for face and skull reconstruction and chest fixation to aid in healing after surgical procedures or trauma.
The company also plays a significant role in dental healthcare, delivering reconstructive implants, prosthetic solutions, regenerative products, and bone cement. Zimmer Biomet is at the forefront of technological advancements in healthcare, integrating robotic and surgical systems into its product offerings to enhance precision and patient outcomes. Its products cater to orthopedic surgeons, neurosurgeons, oral surgeons, dentists, and hospitals worldwide, supported by a network of distributors and healthcare specialists. Moreover, the company collaborates with healthcare purchasing organizations and buying groups to ensure broad accessibility and efficient delivery of its medical solutions.
Founded in 1927 and originally known as Zimmer Holdings, Inc., the company rebranded as Zimmer Biomet Holdings, Inc. in 2015. Headquartered in Warsaw, Indiana, Zimmer Biomet continues to uphold a legacy of innovation and excellence in musculoskeletal healthcare, addressing diverse patient needs through its comprehensive product portfolio and commitment to advancing medical technologies.
Zimmer Biomet stock FAQ
What is the Zimmer Biomet stock ticker symbol?
Zimmer Biomet Holdings, Inc. trades on the NYSE under the ticker symbol ZBH.
What sector and industry is Zimmer Biomet in?
Zimmer Biomet Holdings, Inc. is classified in the Healthcare sector, Medical Devices industry.
How many employees does Zimmer Biomet have?
Zimmer Biomet Holdings, Inc. has about 17,000 full-time employees.
What were Zimmer Biomet's revenue and earnings last fiscal year?
Zimmer Biomet reported revenue of $8.23B and net income of $705.2M in fiscal 2025, with earnings per share of $8.20. Revenue grew 7.2% from the prior year.
Is Zimmer Biomet in the S&P 500?
Yes. Zimmer Biomet Holdings, Inc. (ZBH) is a component of the S&P 500, the index of 500 leading U.S. companies widely used as a benchmark for the U.S. stock market.
Is Zimmer Biomet in the Russell 1000?
Yes. Zimmer Biomet Holdings, Inc. (ZBH) is a component of the Russell 1000, which tracks roughly the 1,000 largest U.S. companies.
When did Zimmer Biomet go public?
Zimmer Biomet stock began trading on July 25, 2001.